| Top 5 Stories : |
|
Pharma Distribution Deals Raise Concerns
A phenomenon is beginning to take hold in pharmaceutical distribution. Large pharmaceutical benefit managers (PBMs) such as Express Scripts Inc. are beginning to use their heft to strike exclusive drug deals in order to lower the cost of healthcare.
Read more
|
|
|
|
|
|
|
Medical Apps Tricky for Pharma
FDA has been under pressure from Congress and IT firms to minimize its regulation of mobile medical apps to prevent stifling innovation in the burgeoning healthcare software field. In response, the agency has divided health-related IT products into three categories, based on whether they warrant more, some, or no oversight.
Read more
|
|
|
Digital Marketing According to HIPAA
Pharmaceutical marketers need to find a new way to offer modern, personalized marketing content that will help them get their message across to the right people, but remain HIPAA compliant at the same time.
Read more
|
|
|
| Trending on Social Media : |
FDA Releases Final Biosimilar Guidance
The documents address comments from various industry perspectives and, according to FDA, “are intended to provide predictability and to make clear the scientific and regulatory considerations for sponsors initiating biosimilar development programs.”
Read more
|
Biogen CEO Highlights Neuroscience Innovation Forum
Pricing and Sovaldi couldn't avoid mention at this week's World Medical Innovation Forum put on by Partners Healthcare in Boston. The meeting highlighted multiple issues in neuroscience but also touched on hot buttons across the industry.
Read more
|
The Power of Proactive Pharmacovigilance
Greater public awareness of drug safety issues and emerging informatics-based methods for acquiring and analyzing medical information, have sparked global initiatives to transform the current largely reactive safety system into one that is proactive, robust, and more useful clinically.
Read more
|
|
|
| Follow Us |
|
|
|
|
